News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News Features Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms Caitlin E. Cox April 23, 2020
News Daily News No ‘Obesity Paradox’: BMI and Infarct Size Not Linked in STEMI Yael L. Maxwell April 22, 2020
Presentation Incidence, Presentation, and Causes of 30-Day Readmission After Hospitalization With SCAD April 20, 2020
News Daily News SCAD Readmissions Common After Acute MI, Especially in Young Women L.A. McKeown April 20, 2020
News Daily News Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers Michael O'Riordan April 15, 2020
News Daily News Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians Caitlin E. Cox April 09, 2020
News Conference News ACC 2020 Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS Todd Neale April 03, 2020
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO Michael O'Riordan March 31, 2020
News Conference News ACC 2020 Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA Shelley Wood March 29, 2020
News Daily News Cardiac Considerations Amid COVID-19: Shared Stories May Save Lives L.A. McKeown March 25, 2020
News Daily News Missed Opportunities: Many HF Patients Not Tested for CAD L.A. McKeown March 20, 2020
News Conference News CRT 2020 Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs Michael O'Riordan February 24, 2020
News Daily News Early CVD Readmissions and Mortality Patterns Differ in Canada and the US Yael L. Maxwell February 18, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Daily News No Fewer MACE With Ticagrelor vs Clopidogrel in ACS Patients After PCI: Registry Todd Neale January 15, 2020
News Daily News Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes Michael O'Riordan January 14, 2020